Key facts
- Bindbridge’s last known valuation is $14.2M (Jun 2025).
- It has raised $7.5M; the latest was Early Stage VC ($3.8M) in Mar 2026.
- Notable investors include Speedinvest, Google Accelerator, Nucleus Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Bindbridge
- ·The full record, as it builds
Funding rounds
No funding rounds for Bindbridge are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bindbridge
Developer of an artificial intelligence-based molecular discovery platform designed to identify molecular glues for agriculture. The company's computational platform enables faster and more cost-effective discovery of herbicides, insecticides, fungicides, and plant trait enhancers using targeted protein degradation, enabling agrochemical companies to develop safer and more effective agricultural products through collaborative research and licensing partnerships.
- Sector
- Healthcare
- HQ
- Impington, United Kingdom
- Founded
- 2024
- Employees
- 7
- Website
- bindbridge.com/
- Ownership
- Privately Held (backing)
Bindbridge doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bindbridge shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bindbridge in its N-PORT filings yet. We sweep new filings monthly.